By-health Co., Ltd. (300146.SZ)
CNY 11.31
(0.09%)
CNY 11.31
(0.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.78 Billion CNY | 15.78% |
| 2022 | 2.4 Billion CNY | -1.15% |
| 2021 | 2.42 Billion CNY | -9.95% |
| 2020 | 2.69 Billion CNY | 12.44% |
| 2019 | 2.39 Billion CNY | -17.34% |
| 2018 | 2.9 Billion CNY | 195.68% |
| 2017 | 981.64 Million CNY | 57.15% |
| 2016 | 624.66 Million CNY | 77.69% |
| 2015 | 351.55 Million CNY | 38.69% |
| 2014 | 253.47 Million CNY | 13.9% |
| 2013 | 222.54 Million CNY | 25.3% |
| 2012 | 177.61 Million CNY | 28.66% |
| 2011 | 138.04 Million CNY | 6.78% |
| 2010 | 129.27 Million CNY | 204.69% |
| 2009 | 42.42 Million CNY | 21.49% |
| 2008 | 34.92 Million CNY | 53.42% |
| 2007 | 22.76 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.88 Billion CNY | -5.58% |
| 2024 Q3 | 2.18 Billion CNY | 15.9% |
| 2024 Q1 | 1.99 Billion CNY | -28.27% |
| 2023 Q1 | 1.87 Billion CNY | -21.79% |
| 2023 Q2 | 1.91 Billion CNY | 1.74% |
| 2023 FY | 2.78 Billion CNY | 15.78% |
| 2023 Q3 | 2.08 Billion CNY | 9.01% |
| 2023 Q4 | 2.78 Billion CNY | 33.48% |
| 2022 Q4 | 2.4 Billion CNY | 33.87% |
| 2022 Q2 | 1.72 Billion CNY | -41.04% |
| 2022 Q1 | 2.93 Billion CNY | 20.69% |
| 2022 FY | 2.4 Billion CNY | -1.15% |
| 2022 Q3 | 1.79 Billion CNY | 3.77% |
| 2021 Q3 | 1.62 Billion CNY | -1.76% |
| 2021 Q1 | 3.05 Billion CNY | 13.09% |
| 2021 FY | 2.42 Billion CNY | -9.95% |
| 2021 Q4 | 2.42 Billion CNY | 49.05% |
| 2021 Q2 | 1.65 Billion CNY | -45.62% |
| 2020 Q1 | 1.69 Billion CNY | -29.47% |
| 2020 FY | 2.69 Billion CNY | 12.44% |
| 2020 Q3 | 2.32 Billion CNY | 15.41% |
| 2020 Q4 | 2.69 Billion CNY | 16.02% |
| 2020 Q2 | 2.01 Billion CNY | 19.07% |
| 2019 FY | 2.39 Billion CNY | -17.34% |
| 2019 Q3 | 2.33 Billion CNY | -9.33% |
| 2019 Q1 | 3.71 Billion CNY | 28.1% |
| 2019 Q4 | 2.39 Billion CNY | 2.64% |
| 2019 Q2 | 2.57 Billion CNY | -30.66% |
| 2018 Q3 | 2.53 Billion CNY | 234.4% |
| 2018 Q2 | 758.68 Million CNY | -40.78% |
| 2018 Q1 | 1.28 Billion CNY | 30.51% |
| 2018 FY | 2.9 Billion CNY | 195.68% |
| 2018 Q4 | 2.9 Billion CNY | 14.4% |
| 2017 Q3 | 718.46 Million CNY | 19.45% |
| 2017 Q2 | 601.45 Million CNY | -33.97% |
| 2017 Q1 | 910.87 Million CNY | 45.82% |
| 2017 FY | 981.64 Million CNY | 57.15% |
| 2017 Q4 | 981.64 Million CNY | 36.63% |
| 2016 Q4 | 624.66 Million CNY | -2.15% |
| 2016 Q3 | 638.38 Million CNY | -0.68% |
| 2016 Q2 | 642.77 Million CNY | -34.4% |
| 2016 Q1 | 979.83 Million CNY | 178.72% |
| 2016 FY | 624.66 Million CNY | 77.69% |
| 2015 Q2 | 340.69 Million CNY | -44.34% |
| 2015 FY | 351.55 Million CNY | 38.69% |
| 2015 Q4 | 351.55 Million CNY | 19.62% |
| 2015 Q3 | 293.88 Million CNY | -13.74% |
| 2015 Q1 | 612.06 Million CNY | 141.47% |
| 2014 Q3 | 236.53 Million CNY | 11.03% |
| 2014 Q2 | 213.04 Million CNY | -57.8% |
| 2014 Q1 | 504.86 Million CNY | 126.86% |
| 2014 FY | 253.47 Million CNY | 13.9% |
| 2014 Q4 | 253.47 Million CNY | 7.17% |
| 2013 Q1 | 268.44 Million CNY | 51.14% |
| 2013 Q2 | 137.04 Million CNY | -48.95% |
| 2013 Q4 | 222.54 Million CNY | 42.86% |
| 2013 FY | 222.54 Million CNY | 25.3% |
| 2013 Q3 | 155.78 Million CNY | 13.67% |
| 2012 Q4 | 177.61 Million CNY | 24.6% |
| 2012 Q3 | 142.55 Million CNY | 21.2% |
| 2012 FY | 177.61 Million CNY | 28.66% |
| 2012 Q2 | 117.61 Million CNY | 6.22% |
| 2012 Q1 | 110.72 Million CNY | -19.79% |
| 2011 FY | 138.04 Million CNY | 6.78% |
| 2011 Q3 | 79.26 Million CNY | 71.19% |
| 2011 Q1 | 49.43 Million CNY | -61.76% |
| 2011 Q2 | 46.29 Million CNY | -6.34% |
| 2011 Q4 | 138.04 Million CNY | 74.17% |
| 2010 Q4 | 129.27 Million CNY | 165.78% |
| 2010 Q2 | 39.28 Million CNY | 0.0% |
| 2010 Q3 | 48.64 Million CNY | 23.81% |
| 2010 FY | 129.27 Million CNY | 204.69% |
| 2009 Q4 | 42.42 Million CNY | 0.0% |
| 2009 FY | 42.42 Million CNY | 21.49% |
| 2008 FY | 34.92 Million CNY | 53.42% |
| 2007 FY | 22.76 Million CNY | 0.0% |